White House Moves to Challenge State AI Laws
White House orders review of state AI laws, pushes for a national framework; agencies may withhold funds over conflicting rules.
Read moreThe National Cancer Institute (NCI) recently announced two new resources for cancer researchers.
The first, the NCI Fiscal Year 2026 (FY26) Annual Plan & Professional Judgment Budget Proposal: Leading Progress Against Cancer, presents NCI’s assessment of the optimal funding needed to fully capitalize on scientific opportunities and advance cancer research. The annual plan highlights four areas of opportunity: Tackling the Emergence of Early-Onset Cancers in Young Adults, Approaching Cancer as a Disease that Affects the Entire Body, Alleviating Financial Toxicity for Cancer Survivors and Caregivers and Expanding the Utility of Cancer-Targeting Vaccines.
The second resource is the NCI Cancer Research Data Commons’ (CRDC) new Clinical and Translational Data Commons (CTDC). Designed to enhance access to clinical and translational data from NCI-funded initiatives, the CTDC is a pivotal resource in accelerating cancer discovery. The goals of the CTDC are to advance cancer research and accelerate the development of innovative therapies by improving access to data from NCI-sponsored clinical studies, including genomic panel assay and clinical data. The CTDC’s inaugural data set comes from the Cancer Moonshot℠ Biobank (CMB), a study collecting clinical data and biospecimens shared by participants throughout their standard of care treatments at participating US medical institutions.
Key features of the CTDC include:
NCI will host a live demonstration of CTDC’s capabilities in the September data science seminar series Sept. 25 at 11am ET.
For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.
White House Moves to Challenge State AI Laws
White House orders review of state AI laws, pushes for a national framework; agencies may withhold funds over conflicting rules.
Read moreACR Chair Takes Part in IAEA Radiation Protection Conference
ACR Chair Alan Matsumoto, MD, joined global leaders at IAEA conference on radiation protection in medicine.
Read moreElevance Health Defends Policy
ACR signed the AMA letter, co-authored a joint letter with ACEP and ASA, and met with Elevance urging fair contracts for patient benefit.
Read more